1. Abstract 1.1. Background & Aim: The degree to which stigma affects the health-related quality of life (HRQoL) of patients with chronic hepatitis B (CHB)-related diseases is not known. We evaluated the HRQoL of patients with CHB-related disease and identified stigma associated with HRQoL. http://dx.doi.org/10.47829/JJGH.2021.6801
1. Abstract 1.1. Background: Adequate staging of colorectal tumors in part depends on obtaining a sufficient number of lymph nodes. The minimum number of lymph nodes required is twelve. A number of factors are known to impact node harvests including, carcinoma grade and size as well as patient age. The impact of neoadjuvant chemotherapy on …
1. Abstract 1.1. Introduction: This retrospective study investigated the outcome of large unresectable Hepatocellular Carcinoma (HCC) in patients with alcoholic and cryptogenic cirrhosis, treated with Trans-Arterial Chemoembolization (TACE). 1.2. Methods: Consecutive 43 cirrhotic patients [Alcoholic group – 25, (M: 25, mean age 62±9.7 SD years, Cryptogenic group – 18, (M: 16, mean age 65±5.6 SD …
1. Abstract Background: Colon cancer is cancer of the large intestine (colon), the lower part of digestive system. Rectal cancer is cancer of the last several inches of the colon. Together, they are often referred to as colorectal cancers. The most common cancers of the large intestine (the type called adenocarcinoma) arise from the mucosa, …
Immunohistochemical Detection of Cytokeratin 20 in Colorectal Carcinoma Read More »
1. Abstract 1.1 Background: Percutaneous Transhepatic Biliary Drainage (PTBD) and endoscopic retrograde biliary drainage (ERBD) had been widely used for unresectable perihilar cholangiocarcinoma (PHC). The optimal type of biliary drainage is still a matter of debate. We aim to compare the efficacy and complications of PTBD and ERBD in the unresectable PHC. http://dx.doi.org/10.47829/JJGH.2021.6702
1. Abstract 1.1. Background & Aims: The potential influence of aspirin and NSAIDs in colorectal cancer screening programs is not clear. We aimed to assess the numbers and sizes of dysplastic polyps detected in colorectal cancer screening of subjects using low-dose aspirin, NSAIDs, and controls. 1.2. Methods: Screening kits were sent to 71026 Scottish citizens, …
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.